Evidence map›Paper›PMID 29196906›Full record

ArticleJournal of cancer education : the official journal of the American Association for Cancer Education2019

Perceptions and Attitudes of Cancer Patients and Caregivers Towards Enrollment in Clinical Trials in Lebanon.

Rana Salem, Charbel Matar, Rita Assi, Raafat Alameddine, Sally Temraz, Ali Shamseddine, Deborah Mukherji

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of cancer education : the official journal of the American Association for Cancer Education, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rana SalemHematology and Oncology Division, Department of Internal Medicine, American University of Beirut, P.O. Box 113-6044, Beirut, Lebanon.
Charbel MatarDepartment of Internal Medicine, American University of Beirut, P.O. Box 113-6044, Beirut, Lebanon.
Rita AssiHematology and Oncology Division, Department of Internal Medicine, American University of Beirut, P.O. Box 113-6044, Beirut, Lebanon.
Raafat AlameddineHematology and Oncology Division, Department of Internal Medicine, American University of Beirut, P.O. Box 113-6044, Beirut, Lebanon.
Sally TemrazHematology and Oncology Division, Department of Internal Medicine, American University of Beirut, P.O. Box 113-6044, Beirut, Lebanon.
Ali ShamseddineHematology and Oncology Division, Department of Internal Medicine, American University of Beirut, P.O. Box 113-6044, Beirut, Lebanon.
Deborah MukherjiHematology and Oncology Division, Department of Internal Medicine, American University of Beirut, P.O. Box 113-6044, Beirut, Lebanon. dm25@aub.edu.lb.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The rates of participation in oncology clinical trials (CTs) are relatively lower in the Middle East compared to other areas in the world. Many social and cultural factors underlie the patients' reluctance to participate. To probe the knowledge, attitudes, and perceptions of patients with cancer and their caregivers regarding participation in CTs at our tertiary referral center in Lebanon, we interviewed 210 patients and caregivers visiting the outpatient clinics in the Naef Basile Cancer Institute at the American University of Beirut. A questionnaire was derived from literature and administered in Arabic. The study was approved by the Institutional Review Board (IRB). Two hundred individuals agreed to answer the questionnaire. The majority of participants (90.5%) were Lebanese with the remaining being non-Lebanese Arabs. Eighty-nine participants (45%) were aware of the concepts of CTs. Eighty-two respondents (41%) would participate in phase I CTs. Twenty-nine individuals (14.5%) agree to be enrolled in CTs with the approval of their family members only. One hundred twenty-nine subjects (64.5%) stated that they would refuse enrollment in a CT where they might receive placebo. Eighty-eight (44%) of participants considered that medical records could be reviewed for research without consent while 54% agreed that samples collected during clinical workup could be used for research without the consent of the patient. There are several social and demographic correlates for participation in CTs. Raising awareness and overcoming barriers of misconception are keys to promote participation in CTs in Lebanon.

Indexed as

Clinical Trials as TopicHealth Knowledge, Attitudes, PracticeNeoplasmsPatient ParticipationResearch SubjectsAdultAgedAged, 80 and overCaregiversFemaleHumansLebanonMaleMiddle AgedSurveys and QuestionnairesAttitudesCancerClinical trialsLebanonPerceptions

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.